Medications as causes of intraluminal hyperdensities: What radiologists need to know

详细信息	查看全文 | 推荐本文 |

• 作者：Francesca Nga Yee Sin^a ; ^{fnysin@yahoo.com.hk} ; Jane Pui Ki Tsang^b ; ¹ ; ^{jane.tsang.pui.ki@gmail.com} ; Kwong Lok Siu^a ; ² ; ^{klsiu@hotmail.com} ; Johnny Ka Fai Ma^a ; ³ ; ^{johnnykfma@hkcr.org} ; Alfred Wei Tak Yung^a ; ⁴ ; ^{awtyung@hotmail.com}
• 关键词：Computed tomography ; Intraluminal hyperdensities ; Medications ; Gastrointestinal bleeding
• 刊名：European Journal of Radiology
• 出版年：2012
• 期刊代码：93_0720048x
• 类别：med
• 出版时间：July, 2012
• 卷：81
• 期：7
• 页码：1652-1656
• 文件大小：1196 K

摘要

In computed tomography (CT) angiogram or some dedicated CT studies of the abdomen, the use of positive enteric contrast should be avoided as its presence could decrease the sensitivity of the test. There are, however, cases of CT scans with unexpected hyperdense intraluminal contents detected due to the use of certain oral or rectal medications. Reports on medications as causes of intraluminal hyperdensities are sparse in the English literature. We have studied several commonly used medications and revealed that many drugs appear hyperdense in CT scans. The presence of unexpected intraluminal hyperdensities can potentially cause erroneous interpretation of images and in some cases decrease the sensitivity of the test. The hyperdense bowel contents may be mistaken as acute hemorrhage in CT angiogram for detection of GI bleeding. Active GI bleeding, presented as intraluminal extravasation of contrast material, can also be obscured. Certain intra-abdominal pathologies could be masked, for example, in plain CT scan for detection of urinary tract stones or in contrast CT study for suspected bowel ischaemia. It is important for radiologists and clinicians to be aware of this situation in order to prevent misinterpretation of images and to select the most appropriate imaging modality when such unexpected intraluminal hyperdensities are encountered.